Aldeyra Therapeutics, Inc. (ALDX)
Nasdaq: ALDX · CIK 0001341235 · United States
Every official Aldeyra Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ALDX filings
Aldeyra Therapeutics, Inc. documents
- Aldeyra Therapeutics, Inc. 10-K 2026ALDX 10-K 2026: annual report for fiscal 2026
- Aldeyra Therapeutics, Inc. 10-K 2025ALDX 10-K 2025: annual report for fiscal 2025
- Aldeyra Therapeutics, Inc. 10-K 2024ALDX 10-K 2024: annual report for fiscal 2024
- Aldeyra Therapeutics, Inc. 10-K 2023ALDX 10-K 2023: annual report for fiscal 2023
- Aldeyra Therapeutics, Inc. 10-K 2022ALDX 10-K 2022: annual report for fiscal 2022
- Aldeyra Therapeutics, Inc. 10-Q 2026ALDX 10-Q 2026: quarterly report for fiscal 2026
- Aldeyra Therapeutics, Inc. 10-Q 2025ALDX 10-Q 2025: quarterly report for fiscal 2025
- Aldeyra Therapeutics, Inc. 10-Q 2024ALDX 10-Q 2024: quarterly report for fiscal 2024
- Aldeyra Therapeutics, Inc. 10-Q 2023ALDX 10-Q 2023: quarterly report for fiscal 2023
- Aldeyra Therapeutics, Inc. 10-Q 2022ALDX 10-Q 2022: quarterly report for fiscal 2022
- Aldeyra Therapeutics, Inc. 8-K 2026ALDX 8-K 2026: current report for fiscal 2026
- Aldeyra Therapeutics, Inc. 8-K 2025ALDX 8-K 2025: current report for fiscal 2025
- Aldeyra Therapeutics, Inc. 8-K 2024ALDX 8-K 2024: current report for fiscal 2024
- Aldeyra Therapeutics, Inc. 8-K 2023ALDX 8-K 2023: current report for fiscal 2023
- Aldeyra Therapeutics, Inc. 8-K 2022ALDX 8-K 2022: current report for fiscal 2022
- Aldeyra Therapeutics, Inc. DEF 14A 2026ALDX DEF 14A 2026: proxy statement for fiscal 2026
- Aldeyra Therapeutics, Inc. DEF 14A 2025ALDX DEF 14A 2025: proxy statement for fiscal 2025
- Aldeyra Therapeutics, Inc. DEF 14A 2024ALDX DEF 14A 2024: proxy statement for fiscal 2024
- Aldeyra Therapeutics, Inc. DEF 14A 2023ALDX DEF 14A 2023: proxy statement for fiscal 2023
- Aldeyra Therapeutics, Inc. DEF 14A 2022ALDX DEF 14A 2022: proxy statement for fiscal 2022
- Aldeyra Therapeutics, Inc. Form 4 2026ALDX Form 4 2026: insider trading filing for fiscal 2026
- Aldeyra Therapeutics, Inc. Form 4 2025ALDX Form 4 2025: insider trading filing for fiscal 2025
- Aldeyra Therapeutics, Inc. Form 4 2024ALDX Form 4 2024: insider trading filing for fiscal 2024
- Aldeyra Therapeutics, Inc. Form 4 2023ALDX Form 4 2023: insider trading filing for fiscal 2023
- Aldeyra Therapeutics, Inc. Form 4 2022ALDX Form 4 2022: insider trading filing for fiscal 2022
- Aldeyra Therapeutics, Inc. S-1 2026ALDX S-1 2026: registration statement for fiscal 2026
- Aldeyra Therapeutics, Inc. S-1 2025ALDX S-1 2025: registration statement for fiscal 2025
- Aldeyra Therapeutics, Inc. S-1 2024ALDX S-1 2024: registration statement for fiscal 2024
- Aldeyra Therapeutics, Inc. S-1 2023ALDX S-1 2023: registration statement for fiscal 2023
- Aldeyra Therapeutics, Inc. S-1 2022ALDX S-1 2022: registration statement for fiscal 2022
- Aldeyra Therapeutics, Inc. 13F 2026ALDX 13F 2026: institutional holdings for fiscal 2026
- Aldeyra Therapeutics, Inc. 13F 2025ALDX 13F 2025: institutional holdings for fiscal 2025
- Aldeyra Therapeutics, Inc. 13F 2024ALDX 13F 2024: institutional holdings for fiscal 2024
- Aldeyra Therapeutics, Inc. 13F 2023ALDX 13F 2023: institutional holdings for fiscal 2023
- Aldeyra Therapeutics, Inc. 13F 2022ALDX 13F 2022: institutional holdings for fiscal 2022
More companies